252 related articles for article (PubMed ID: 28148500)
1. The influence of genetic susceptibility and calcium plus vitamin D supplementation on fracture risk.
Wang Y; Wactawski-Wende J; Sucheston-Campbell LE; Preus L; Hovey KM; Nie J; Jackson RD; Handelman SK; Nassir R; Crandall CJ; Ochs-Balcom HM
Am J Clin Nutr; 2017 Apr; 105(4):970-979. PubMed ID: 28148500
[No Abstract] [Full Text] [Related]
2. Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women.
Wang Y; Wactawski-Wende J; Sucheston-Campbell LE; Preus L; Hovey KM; Nie J; Jackson RD; Handelman SK; Nassir R; Crandall CJ; Ochs-Balcom HM
J Clin Endocrinol Metab; 2017 Jun; 102(6):1908-1916. PubMed ID: 28324062
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
4. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.
Bolland MJ; Grey A; Gamble GD; Reid IR
Am J Clin Nutr; 2011 Oct; 94(4):1144-9. PubMed ID: 21880848
[TBL] [Abstract][Full Text] [Related]
5. Women's Health Initiative clinical trials: interaction of calcium and vitamin D with hormone therapy.
Robbins JA; Aragaki A; Crandall CJ; Manson JE; Carbone L; Jackson R; Lewis CE; Johnson KC; Sarto G; Stefanick ML; Wactawski-Wende J
Menopause; 2014 Feb; 21(2):116-23. PubMed ID: 23799356
[TBL] [Abstract][Full Text] [Related]
6. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
[TBL] [Abstract][Full Text] [Related]
7. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis.
Bergman GJ; Fan T; McFetridge JT; Sen SS
Curr Med Res Opin; 2010 May; 26(5):1193-201. PubMed ID: 20302551
[TBL] [Abstract][Full Text] [Related]
9. The effect of calcium and vitamin D3 supplementation on the healing of the proximal humerus fracture: a randomized placebo-controlled study.
Doetsch AM; Faber J; Lynnerup N; Wätjen I; Bliddal H; Danneskiold-Samsøe B
Calcif Tissue Int; 2004 Sep; 75(3):183-8. PubMed ID: 15386160
[TBL] [Abstract][Full Text] [Related]
10. Calcium plus vitamin D supplementation has limited effects on femoral geometric strength in older postmenopausal women: the Women's Health Initiative.
Jackson RD; Wright NC; Beck TJ; Sherrill D; Cauley JA; Lewis CE; LaCroix AZ; LeBoff MS; Going S; Bassford T; Chen Z
Calcif Tissue Int; 2011 Mar; 88(3):198-208. PubMed ID: 21253715
[TBL] [Abstract][Full Text] [Related]
11. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials.
Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV
Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Bone Mineral Density and Fragility Fracture by Genetic Profiling.
Ho-Le TP; Center JR; Eisman JA; Nguyen HT; Nguyen TV
J Bone Miner Res; 2017 Feb; 32(2):285-293. PubMed ID: 27649491
[TBL] [Abstract][Full Text] [Related]
13. Association of Protein Intake with Bone Mineral Density and Bone Mineral Content among Elderly Women: The OSTPRE Fracture Prevention Study.
Isanejad M; Sirola J; Mursu J; Kröger H; Tuppurainen M; Erkkilä AT
J Nutr Health Aging; 2017; 21(6):622-630. PubMed ID: 28537325
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
[TBL] [Abstract][Full Text] [Related]
15. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.
Rabenda V; Bruyère O; Reginster JY
Osteoporos Int; 2011 Mar; 22(3):893-901. PubMed ID: 21060990
[TBL] [Abstract][Full Text] [Related]
16. Genetically determined vitamin D levels and change in bone density during a weight-loss diet intervention: the Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial.
Zhou T; Sun D; Heianza Y; Li X; Champagne CM; LeBoff MS; Shang X; Pei X; Bray GA; Sacks FM; Qi L
Am J Clin Nutr; 2018 Nov; 108(5):1129-1134. PubMed ID: 30475961
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
Liu C; Kuang X; Li K; Guo X; Deng Q; Li D
Food Funct; 2020 Dec; 11(12):10817-10827. PubMed ID: 33237064
[TBL] [Abstract][Full Text] [Related]
18. Calcium plus vitamin D supplementation and the risk of fractures.
Jackson RD; LaCroix AZ; Gass M; Wallace RB; Robbins J; Lewis CE; Bassford T; Beresford SA; Black HR; Blanchette P; Bonds DE; Brunner RL; Brzyski RG; Caan B; Cauley JA; Chlebowski RT; Cummings SR; Granek I; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Johnson KC; Judd H; Kotchen JM; Kuller LH; Langer RD; Lasser NL; Limacher MC; Ludlam S; Manson JE; Margolis KL; McGowan J; Ockene JK; O'Sullivan MJ; Phillips L; Prentice RL; Sarto GE; Stefanick ML; Van Horn L; Wactawski-Wende J; Whitlock E; Anderson GL; Assaf AR; Barad D;
N Engl J Med; 2006 Feb; 354(7):669-83. PubMed ID: 16481635
[TBL] [Abstract][Full Text] [Related]
19. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women.
Salmen T; Heikkinen AM; Mahonen A; Kröger H; Komulainen M; Pallonen H; Saarikoski S; Honkanen R; Mäenpää PH
Ann Med; 2003; 35(4):282-8. PubMed ID: 12846271
[TBL] [Abstract][Full Text] [Related]
20. Multiple gene polymorphisms can improve prediction of nonvertebral fracture in postmenopausal women.
Lee SH; Lee SW; Ahn SH; Kim T; Lim KH; Kim BJ; Cho EH; Kim SW; Kim TH; Kim GS; Kim SY; Koh JM; Kang C
J Bone Miner Res; 2013 Oct; 28(10):2156-64. PubMed ID: 23572424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
